Detailed Information
Cited 2 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Adjuvant erlotinib (E) versus placebo (P) in non-small cell lung cancer (NSCLC) patients (pts) with tumors carrying EGFR-sensitizing mutations from the RADIANT trial.
- Authors
- Shepherd, Frances A.; Altorki, Nasser K.; Eberhardt, Wilfried Ernst Erich; O'Brien, Mary E. R.; Spigel, David R.; Crino, Lucio; Tsai, Chun-Ming; Kim, Joo-Hang; Cho, Eun Kyung; Szczesna, Aleksandra; Burghuber, Otto; Hoffman, Philip C.; Keshavjee, Shaf; Orlov, Sergey; Serwatowski, Piotr; Wang, Jiuzhou; Foley, Margaret A.; Horan, Julie D.; Richardson, Frank C.; Kelly, Karen
- Issue Date
- 20-May-2014
- Publisher
- AMER SOC CLINICAL ONCOLOGY
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.32, no.15
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 32
- Number
- 15
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Cho, Eun Kyung
- College of Medicine (Department of Medicine)